4.7 Article

Molecular Epidemiology of Aspergillus fumigatus Isolates Harboring the TR34/L98H Azole Resistance Mechanism

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 50, 期 8, 页码 2674-2680

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00335-12

关键词

-

资金

  1. Wellcome Trust (United Kingdom)
  2. Basilea
  3. Bio-Rad
  4. Gilead
  5. Merck
  6. Pfizer
  7. Schering-Plough
  8. Janssen Pharmaceutica

向作者/读者索取更多资源

A rapid emergence of azole resistance has been observed in Aspergillus fumigatus in The Netherlands over the past decade. The dominant resistance mechanism appears to be of environmental origin and involves the TR34/L98H mutations in cyp51A. This resistance mechanism is now also increasingly being found in other countries. Therefore, genetic markers were used to gain more insights into the origin and spread of this genotype. Studies of 142 European isolates revealed that those with the TR34/L98H resistance mechanism showed less genetic variation than azole-susceptible isolates or those with a different genetic basis of resistance and were assigned to only four CSP (putative cell surface protein) types. Sexual crossing experiments demonstrated that TR34/L98H isolates could outcross with azole-susceptible isolates of different genetic backgrounds, suggesting that TR34/L98H isolates can undergo the sexual cycle in nature. Overall, our findings suggest a common ancestor of the TR34/L98H mechanism and subsequent migration of isolates harboring TR34/L98H across Europe.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据